Welcome to Multibagg AI
Log in to access personalized features
Discovery themes featuring this stockBearish
3
Neutral
6
Bullish
5
Bearish
10
Neutral
6
Bullish
30
Bearish
7
Neutral
0
Bullish
25
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Dashboard
Portfolio
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Chemcrux Enterprises Limited primarily manufactures intermediates for bulk drugs, dyes, and pigments using specialized chemical processes like high-pressure oxidation and chlorosulfonation.
The company has established a robust clientele comprising both multinational corporations and leading pharmaceutical organizations in India and has a consistent export presence in multiple countries.
Chemcrux has been operational in its current corporate structure since 2000, following the acquisition of a partnership firm, though its origins date back to 1981.
The company went public in March 2017, issuing equity shares to raise substantial funds for its operations and growth.
Chemicals & Petrochemicals
Specialty Chemicals
139 Cr
Moderate Risk
66.5
44.3
-1.0
1.9
170.00
64.00
Sales CAGR
Profit CAGR
ROE
ROCE
Upcoming Result Date: May 13, 2026
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Chemcrux Enterprises Ltd (CHEMCRUX) is currently trading at 93.90 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Chemcrux Enterprises Limited primarily manufactures intermediates for bulk drugs, dyes, and pigments using specialized chemical processes like high-pressure oxidation and chlorosulfonation. The company has established a robust clientele comprising both multinational corporations and leading pharmaceutical organizations in India and has a consistent export presence in multiple countries. Chemcrux has been operational in its current corporate structure since 2000, following the acquisition of a partnership firm, though its origins date back to 1981. The company went public in March 2017, issuing equity shares to raise substantial funds for its operations and growth.
Over the past 52 weeks, Chemcrux Enterprises Ltd has traded between a low of ₹64.00 and a high of ₹170.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Chemcrux Enterprises Ltd has a market capitalization of approximately 138.91. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Chemcrux Enterprises Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 66.46 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 138.91 Cr, Chemcrux Enterprises Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Chemcrux Enterprises Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Chemcrux Enterprises Ltd is 66.46. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
62.09 | 169 Cr | -17.37 | 1.15 | 0.00 | -3.16 | 0.89 | -4.08 | ||
136.00 | 162 Cr | 11.90 | 1.13 | 0.64 | 7.57 | 9.51 | 4.12 | ||
11800.00 | 141 Cr | 27.92 | 1.10 | 0.00 | 3.96 | 6.28 | 2.66 | ||
68.45 | 139 Cr | 66.46 | 1.86 | 1.07 | 2.45 | 5.21 | 1.68 | ||
99.00 | 125 Cr | 14.16 | 2.01 | 0.92 | 11.28 | 15.62 | 10.91 | ||
112.10 | 121 Cr | 13.50 | 3.35 | 0.00 | 17.98 | 23.26 | 12.85 | ||
89.75 | 100 Cr | 9.04 | 1.82 | 0.00 | 18.63 | 24.60 | 16.63 | ||
| Median: 7 Co. | — | 99.00 | 139 Cr | 13.50 | 1.82 | 0.00 | 7.57 | 9.51 | 4.12 |
Board Meeting - Financial Results
Board to meet on 14 May 2026 at 11:30 AM to consider and approve audited financial results for Q4/FY2025-26 and to consider recommending a final dividend (subject to AGM approval); Audit Committee to meet earlier; trading window reopens 48 hrs after results.
Board meeting - Results
Chemcrux Enterprises will hold a Board meeting on 14 May 2026 to consider and approve audited financial statements and results for the quarter and year ended 31 Mar 2026, and may recommend a final dividend; Audit Committee to meet earlier.
